CD44 and neoplasm: And the expression of stemness markers, OCT4 and Nanog, which were down-regulated in tumor tissues from the subcutaneous implantation models of CD133+/CD44+ cells with shOPN/EV, were partly rescued by introduction of DNMT1 (Fig. 5f).